Physician profile
Chad Carlsson
NPI 1508853904
$12,842.44
in general payments reported to CMS, 2019-2025
20 companies · $546 in 2025
The $546 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,172 · 2020: $3,266 · 2021: $683 · 2022: $880 · 2023: $2,031 · 2024: $263 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548 · Consulting Fee: $1,000 · Travel and Lodging: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,547.87 |
| Consulting Fee | $1,000.00 |
| Travel and Lodging | $292.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $6,925.03 | 2019-2020 | |
| Coopervision INC. | $2,347.87 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Onefit Contact Lens |
| Optovue, INC. | $710.07 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $662.50 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $575.90 | 2019-2025 | Total30, Precision7, Dailies Total1 |
| Topcon Healthcare, INC. | $241.26 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $168.13 | 2019-2021 | |
| Glaukos Corporation | $136.79 | 2024 | Ce-Marked Kxla System |
| Johnson & Johnson Surgical Vision, INC. | $127.04 | 2021-2022 | |
| Abbvie INC. | $126.33 | 2023 | Durysta |
| Biotissue Holdings INC. | $121.54 | 2022 | |
| Mallinckrodt Hospital Products INC. | $119.05 | 2022 | |
| Horizon Therapeutics Plc | $114.77 | 2022 | |
| Lkc Technologies, INC. | $99.50 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $98.02 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $95.76 | 2023 | Cequa |
| Oyster Point Pharma, INC. | $90.39 | 2023 | Tyrvaya |
| Maculogix, INC. | $29.00 | 2020 | |
| Bausch & Lomb Americas INC. | $27.82 | 2025 | Biotrue, Infuse |
| Optos, INC. | $25.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Carlsson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.